OC
MJN

Oppenheimer & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Oppenheimer & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,531
Closed -$226K – 1390
2017
Q1 		$226K Sell
2,531
-8,249
-77% -$678K 0.01% 1116
2016
Q4 		$763K Buy
10,780
+5,391
+100% +$402K 0.02% 649
2016
Q3 		$426K Buy
5,389
+772
+17% +$65.8K 0.01% 874
2016
Q2 		$419K Buy
4,617
+467
+11% +$39.5K 0.01% 847
2016
Q1 		$352K Buy
4,150
+1,404
+51% +$104K 0.01% 879
2015
Q4 		$217K Buy
+2,746
New +$216K 0.01% 1094
2015
Q2 		– Sell
-5,745
Closed -$578K – 1607
2015
Q1 		$578K Buy
5,745
+98
+2% +$9.88K 0.02% 810
2014
Q4 		$568K Buy
5,647
+2,448
+77% +$244K 0.02% 774
2014
Q3 		$307K Buy
3,199
+480
+18% +$45.5K 0.01% 1063
2014
Q2 		$254K Sell
2,719
-719
-21% -$62.9K 0.01% 1139
2014
Q1 		$286K Buy
3,438
+719
+26% +$58.3K 0.01% 1059
2013
Q4 		$228K Hold
2,719
– – 0.01% 1149
2013
Q3 		$202K Hold
2,719
– – 0.01% 1156
2013
Q2 		$215K Buy
+2,719
New +$218K 0.01% 1078

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Oppenheimer & Co's MJN Position: Q2 2017 in Review

Oppenheimer & Co sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,531 shares — an estimated $226K sold.

Oppenheimer & Co first reported a position in MJN in Q2 2013 and held it in 14 quarters. The position peaked at $763K in Q4 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Oppenheimer & Co reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 2,531 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $226K.
  • Oppenheimer & Co first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 14 quarters.
  • Oppenheimer & Co's Mead Johnson Nutrition Company position peaked at $763K in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Oppenheimer & Co's 13F filing for Q2 2017, filed 9 Aug 2017.